| http://www.w3.org/ns/prov#value | - oing cellular interaction with denatured collagen type-IV. [0072] The antagonist can be conjugated with a cytostatic agent such as an anti-angiogenic compound, for delivery to a tumor or other tissue undergoing angiogenesis, tumor growth, metastasis, arthritis or other disease or condition associated with cellular interactions with denatured collagen type-IV. A preferred cytostatic agent is a matr
|
